Edition:
Deutschland

Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

0.72USD
24 May 2017
Change (% chg)

-- (--)
Prev Close
$0.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
46,195
52-wk High
$5.97
52-wk Low
$0.66

TROV.OQ

Chart for TROV.OQ

About

Trovagene, Inc. (TrovaGene) is a molecular diagnostic company. The Company focuses on the development and commercialization of a molecular diagnostic technology for use in disease detection and monitoring across a range of medical disciplines. Its primary internal focus is to leverage its cell-free molecular diagnostic platform... (more)

Buy/Sell

Sell Hold Buy
2.00 Mean rating from 1 analysts

Overall

Beta: 0.82
Market Cap(Mil.): $28.72
Shares Outstanding(Mil.): 30.97
Dividend: --
Yield (%): --

BRIEF-Trovagene reports Q4 loss per share $0.34

* Trovagene reports fourth quarter and year end 2016 financial results

BRIEF-Trovagene, Nerviano announce license agreement for therapeutic candidate PCM-075

* Trovagene and Nerviano announce license agreement for therapeutic candidate PCM-075

BRIEF-Trovagene says publication of trovera kras liquid biopsy test demonstrates clinical utility in advanced cancers for detection and measurement of therapeutic response

* Trovagene - publication of trovera kras liquid biopsy test demonstrates clinical utility in advanced cancers for detection and measurement of therapeutic response Source text for Eikon: Further company coverage:

BRIEF-Trovagene to accelerate global distribution of liquid biopsy technology

* Estimates program will reduce annual pre-tax expenses by about $4.0m per year mainly through reduction of about 20 personnel and expenses

BRIEF-Trovagene and Boreal Genomics announce strategic partnership

* Press release - Trovagene and Boreal Genomics announce strategic partnership

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.16%
Rohstoffe +0.05%
Industrie -0.05%
Konjunktur abhängige Waren & Dienstleistungen +0.02%
Konjunktur unabhängige Waren & Dienstleistungen +0.03%
Finanzindustrie -0.03%
Pharma +0.01%
Technologie +0.26%
Telekommunikation +0.21%